Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $26,100,000, representing a 25.9% increase year over year, contributing to the largest first half revenue performance in company history [5][14][27] - Gross margins expanded by 180 basis points to 51.3%, marking the ninth consecutive quarter of year-over-year gross margin expansion [14][28] - Adjusted EBITDA was $300,000, indicating the fifth consecutive quarter of adjusted EBITDA profitability [5][14][31] - Net loss for Q2 was $37,600,000, primarily due to a non-cash mark to market adjustment related to common stock warrant liability [29][30] Business Line Data and Key Metrics Changes - Domestic sell-through growth for DreamSoc was 37% year over year, with a 54% increase in total DreamSoc additions to registries [16][20] - International revenue decreased to $1,800,000 from $4,800,000 year over year, attributed to a timing shift of open orders to Q3 [20][21] - The Outlet 360 subscription surpassed 66,000 paying subscribers, showing strong growth in monthly recurring revenue and retention rates [22][63] Market Data and Key Metrics Changes - Owlette maintained market leadership in the baby monitor category, increasing its share of total dollars spent on baby monitors compared to the prior year [17] - The overall category for baby monitors is experiencing the highest consumer spending in five years [17] - International sell-through units in the UK increased by 144%, while France and Germany saw increases of over 200% and 100% year over year, respectively [21] Company Strategy and Development Direction - The company is focused on transforming into a comprehensive pediatric health platform, emphasizing the expansion of the Outlet 360 subscription and increasing customer lifetime value [6][24] - Plans to roll out telehealth services by the end of the year, enhancing the integration of health data with healthcare providers [24][58] - The company is exploring alternative manufacturing locations to mitigate the impact of increased tariffs [70] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued momentum into the second half of the year and raised full-year guidance based on strong Q2 performance [6][32] - The leadership transition is expected to further accelerate growth, with Jonathan Harris taking over as CEO [7][12] - Management acknowledged the fluidity of the macroeconomic environment, particularly regarding tariff policies, which could impact future guidance [32] Other Important Information - The company announced an agreement to exchange Series A and Series B warrants for common stock, simplifying its capital structure [30][73] - The company received recognition for innovation in baby care, winning awards for its DreamSoc product [19][20] Q&A Session Summary Question: Can you quantify the tariff cost impact on cost of goods sold? - The impact was about $500,000 in Q2, with expectations of a 5% impact on gross margin in Q4 due to increased tariffs [36][37] Question: What is the progress on the healthcare side with DME vendors? - Revenue from healthcare remains inconsequential, but adoption of Medicaid plans is increasing, and integration with CHKD is progressing [42] Question: What is the process for bringing another hospital on board? - The process involves committee approvals and integration into existing remote patient monitoring platforms [68] Question: Is there a strategy to bring manufacturing to the US or another country with lower tariffs? - The company is actively exploring other manufacturing sites to diversify sourcing and minimize tariff impacts [70]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $21.1 million, representing a 43% increase year over year compared to Q1 2024 [11][27] - Gross margin improved to 53.7%, an increase of 930 basis points year over year, marking the eighth consecutive quarter of gross margin expansion [12][27] - Adjusted EBITDA was breakeven, an improvement of $3.1 million year over year, indicating the fourth consecutive quarter of breakeven or better adjusted EBITDA [12][29] - Operating loss decreased to $2.7 million from $5.7 million in the same period last year [28] Business Line Data and Key Metrics Changes - The DreamSoc and Dream Duo products showed strong performance, with domestic sell-through growth of 40% year over year [18] - The Owlet three sixty subscription service gained over 48,000 paying subscribers shortly after its launch, indicating strong market adoption [20] Market Data and Key Metrics Changes - International revenue growth was up 104% year over year, with notable performance in France and Germany [19] - Baby registries showed a 63% year over year increase in DreamSoc, reflecting strong consumer interest [18] Company Strategy and Development Direction - The company is transitioning from a hardware-focused business to a comprehensive pediatric health platform, emphasizing the Owlet three sixty subscription service [13][60] - New distribution partnerships, such as with the Children's Hospital of the King's Daughters, are aimed at expanding market reach and enhancing product visibility [7][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating macroeconomic uncertainties, including tariff impacts, and highlighted the company's strong positioning to capture market share [13][15] - The updated 2025 revenue guidance was raised to a range of $91 million to $95 million, reflecting the strong start to the year and ongoing momentum [30][31] Other Important Information - The company has minimized its manufacturing exposure to China by transitioning production to Vietnam and Thailand [15] - The company is actively assessing the impact of new tariffs on its operations and has included these considerations in its financial outlook [31] Q&A Session Summary Question: Can you explain the partnership with the Children's Hospital of the King's Daughters? - The partnership allows babies to leave the hospital with an Owlet infant health monitor, integrating Owlet data into remote patient monitoring workflows [36] Question: What is the feedback on the Owlet three sixty subscription service? - Feedback has been overwhelmingly positive, with parents appreciating access to insights about their baby's health and sleep [38] Question: How should revenue cadence be expected throughout the year? - Sequential growth is expected each quarter, with Q4 anticipated to be the largest due to the holiday season [42] Question: Can you provide insight into the overall marketing strategy for 2025? - The marketing strategy focuses on FDA and CE medical clearances and enhancing communication with parents through various channels [46] Question: Are there any shifts in consumer behavior due to macroeconomic challenges? - Currently, there are no significant shifts observed, and the company remains cautiously optimistic [48] Question: How is the awareness of the Owlet three sixty subscription being raised? - In-app messaging, email, and SMS are being utilized to increase awareness among new parents [50] Question: Do you see any competitive advantages due to tariffs affecting competitors? - Yes, many competitors are exposed to high tariffs, which presents an opportunity for Owlet to capture additional market share [55]

Owlet, Inc. (NYSE: OWLT) Q4 2024 Financial Results March 4, 2025 Owlet, Inc. (NYSE: OWLT) | Q4 2024 Financial Results Conference Call Speakers Webcast Contacts | 2 ● Kurt Workman, CEO and Co-Founder ● Jonathan Harris, President and CRO ● Amanda Twede Crawford, CFO ● Jay Gentzkow, VP Investor Relations ● Domestic Callers: (833) 470-1428 ● International Callers: (404) 975-4839; Access Code: 492081 ● Webcast Archive Available: investors.owletcare.com 1 March 4, 2025 Non-GAAP Financial Measures In addition to t ...